Boston Scientific (BSX) Change in Accured Expenses (2020 - 2026)
Boston Scientific (BSX) posted quarterly Change in Accured Expenses of $234.0 million for Q2 2026, up 1.3% year-over-year from $231.0 million in Q2 2025, and up 145.7% on a QoQ basis from -$512.0 million in Q1 2026.
Boston Scientific (BSX) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Boston Scientific has reported Change in Accured Expenses for 7 years, with the latest figure at $234.0 million in Q2 2026.
- Change in Accured Expenses for Q2 2026 came in at $234.0 million, up 1.3% year-over-year; the trailing twelve-month figure through Jun 2026 was $172.0 million (down 63.25% YoY), and the FY2025 annual result was $296.0 million, up 21.81% from the prior year.
- Change in Accured Expenses improved to $234.0 million in Q2 2026, from -$512.0 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $385.0 million in Q4 2024 and troughed at -$512.0 million in Q1 2026.
- A 5-year average of $6.9 million and a median of $47.0 million in 2023 frame the typical range for Change in Accured Expenses.
- The widest annual swing landed in 2022, when Change in Accured Expenses slumped 5357.14%; it then soared 1573.91% in 2024.
- A 5-year view of Change in Accured Expenses shows it stood at $335.0 million in 2022, then sank by 93.13% to $23.0 million in 2023, then soared by 1573.91% to $385.0 million in 2024, then slipped by 25.97% to $285.0 million in 2025, then declined by 17.89% to $234.0 million in 2026.
- Per Business Quant data, the three most recent Change in Accured Expenses figures were $234.0 million in Q2 2026, -$512.0 million in Q1 2026, and $285.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | 92.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 234.00 Mn |
| Jun 30, 2026 | 234.00 Mn |
| Mar 31, 2026 | -512.00 Mn |
| Mar 31, 2026 | -512.00 Mn |
| Dec 31, 2025 | 285.00 Mn |
| Dec 31, 2025 | 285.00 Mn |
| Sep 30, 2025 | 165.00 Mn |
| Sep 30, 2025 | 165.00 Mn |
| Jun 30, 2025 | 231.00 Mn |
| Jun 30, 2025 | 231.00 Mn |
| Mar 31, 2025 | -385.00 Mn |
| Mar 31, 2025 | -385.00 Mn |
| Dec 31, 2024 | 385.00 Mn |
| Dec 31, 2024 | 385.00 Mn |
| Sep 30, 2024 | 237.00 Mn |
| Sep 30, 2024 | 237.00 Mn |
| Jun 30, 2024 | 71.00 Mn |
| Jun 30, 2024 | 71.00 Mn |
| Mar 31, 2024 | -450.00 Mn |
| Mar 31, 2024 | -450.00 Mn |